Neuroendocrine Tumor
What's New
Last Posted: May 11, 2023
- Pancreatic Cancer Screening for At-risk Individuals (Pancreas Scan Study): Yield, Harms and Outcomes from a Prospective Multi-Center Study.
Ishani Shah et al. Am J Gastroenterol 2023 - Artificial intelligence-based diagnosis of upper gastrointestinal subepithelial lesions on endoscopic ultrasonography images.
Hirai Keiko et al. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2021 - Clinically actionable findings on surveillance EGD in asymptomatic patients with Lynch syndrome.
Farha Natalie et al. Gastrointestinal endoscopy 2021 - A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) Therapy.
Hasic Telalovic Jasminka et al. Diagnostics (Basel, Switzerland) 2021 11(5) - Genetic Characteristics of Colorectal Neuroendocrine Carcinoma: More Similar to Colorectal Adenocarcinoma.
Chen Luohai et al. Clinical colorectal cancer 2020 Sep - Assessment of NETest Clinical Utility in a U.S. Registry-Based Study.
Liu Eric et al. The oncologist 2019 24(6) 783-790 - Improving the accuracy of gastrointestinal neuroendocrine tumor grading with deep learning.
Govind Darshana et al. Scientific reports 2020 Jul 10(1) 11064 - Inherited syndromes involving pancreatic neuroendocrine tumors.
Geurts Jennifer L et al. Journal of gastrointestinal oncology 2020 Jun 11(3) 559-566 - Utility of a ready-to-use PCR system for neuroendocrine tumor diagnosis.
Kidd Mark et al. PloS one 2019 14(6) e0218592 - The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors.
Malczewska Anna et al. Advances in medical sciences 2019 Dec 65(1) 18-29
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: